Clara Bodelón

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

Association of gene variant type and location with breast cancer risk in the general population

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

Germline pathogenic variants in cancer predisposition genes and overall survival of women with breast cancer.

Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i> -deficient tubo-ovarian high-grade serous carcinoma

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction

Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma <i>In Situ</i> of the Breast

Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies new candidate susceptibility genes for breast and ovarian cancer

Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer